Imperial College London

Running trials

• Recruiting

  BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.

  NCT06611306· Source

• Not yet recruiting

  3D Reconstruction, VR and Machine Learning in Body Image in Bariatrics

  NCT07668492· Source

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Source

• Recruiting

  A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  NCT07070232· Phase 1/2· Source

• Recruiting

  pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure

  NCT07029906· Source

• Recruiting

  Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study

  NCT06953167· Source

• Not yet recruiting

  Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection

  NCT06453785· Source

• Recruiting

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· Phase 3· Source

• Recruiting

  A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions

  NCT06864195· Source

• Recruiting

  Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

  NCT06334575· Phase 4· Source

• Recruiting

  Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants

  NCT06823466· Source

• Recruiting

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· Phase 3· Source

• Recruiting

  Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

  NCT05955365· Phase 4· Source

• Active, not recruiting

  An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

  NCT05876754· Phase 3· Source

• Active, not recruiting

  A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

  NCT05567796· Phase 3· Source

• Recruiting

  Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

  NCT05533697· Phase 1/2· Source

• Recruiting

  Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  NCT05429632· Phase 3· Source

• Recruiting

  The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

  NCT05885295· Source

• Recruiting

  Tumour Characterisation to Guide Experimental Targeted Therapy - National

  NCT04723316· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Source

• Active, not recruiting

  Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

  NCT04449406· Source

• Recruiting

  The Heart Hive - Cardiomyopathy Study

  NCT04612296· Source

• Recruiting

  The Poor Responders Study

  NCT05404061· Source

• Active, not recruiting

  A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  NCT03522246· Phase 3· Source

• Recruiting

  EAS Familial Hypercholesterolaemia Studies Collaboration

  NCT04272697· Source

• Active, not recruiting

  Prostate Advances in Comparative Evidence

  NCT01584258· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Alzheimer disease2 recruiting
• Atrial fibrillation2 recruiting
• Obesity2 recruiting
• Sickle cell disease2 recruiting
• Stroke2 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Frontotemporal dementia1 recruiting
• Gastric and esophageal cancer1 recruiting
• Heart failure1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Parkinson disease1 recruiting
• Prostate cancer1 recruiting
• Thalassaemia1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer

  NCT06189846· Source

• Completed

  A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

  NCT05558696· Phase 2· Source

• Completed

  Non-Eosinophilic Biological Effects of IL-5

  NCT06026202· Source

• Withdrawn

  Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia

  NCT03761511· Phase 2· Source

• Completed

  Google Location History Following Oesophagectomy and/or Gastrectomy

  NCT05035602· Source

• Completed

  Advanced Ultrasound Applications for Predicting AVF Outcomes

  NCT04141358· Source

• Completed

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· Phase 2· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Source

• Completed

  Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients

  NCT06453993· Source

Trial sites

• Department of Brain Sciences, Imperial College London1 trial
• Imperial College London33 trials
• Imperial College London - Imperial College Memory Research Centre2 trials
• Imperial College London (Site 0025)1 trial
• School of Public Health, Imperial College London1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke330 works · 2 trials
• Obesity325 works · 3 trials
• Asthma299 works · 1 trial
• Heart failure288 works · 1 trial
• Alzheimer disease260 works · 4 trials
• HIV229 works · 0 trials
• Type 2 diabetes196 works · 1 trial
• Atrial fibrillation185 works · 2 trials
• Tuberculosis137 works · 0 trials
• COPD131 works · 1 trial
• Lung cancer131 works · 1 trial
• Colorectal cancer125 works · 1 trial
• Liver and biliary tract cancer109 works · 2 trials
• Coronary artery disease103 works · 0 trials
• Idiopathic pulmonary fibrosis84 works · 0 trials
• Chronic kidney disease80 works · 1 trial
• Parkinson disease78 works · 1 trial
• Ovarian cancer72 works · 1 trial
• Crohn's disease72 works · 1 trial
• Schizophrenia71 works · 0 trials
• Ulcerative colitis68 works · 0 trials
• Cystic fibrosis64 works · 0 trials
• Prostate cancer61 works · 2 trials
• Multiple sclerosis56 works · 0 trials
• Pulmonary arterial hypertension55 works · 0 trials
• Type 1 diabetes52 works · 0 trials
• Melanoma51 works · 1 trial
• Pancreatic cancer46 works · 1 trial
• Depression46 works · 0 trials
• Cervical cancer39 works · 0 trials